367 filings
Page 3 of 19
CORRESP
ATXI
Avenue Therapeutics Inc
30 Oct 23
Correspondence with SEC
12:00am
CORRESP
ATXI
Avenue Therapeutics Inc
30 Oct 23
Correspondence with SEC
12:00am
CORRESP
ATXI
Avenue Therapeutics Inc
27 Oct 23
Correspondence with SEC
12:00am
CORRESP
ATXI
Avenue Therapeutics Inc
27 Oct 23
Correspondence with SEC
12:00am
CORRESP
ATXI
Avenue Therapeutics Inc
24 Oct 23
Correspondence with SEC
12:00am
CORRESP
ATXI
Avenue Therapeutics Inc
24 Oct 23
Correspondence with SEC
12:00am
S-1/A
ATXI
Avenue Therapeutics Inc
IPO registration (amended)
23 Oct 23
8:50pm
FWP
ATXI
Avenue Therapeutics Inc
5 Oct 23
Free writing prospectus
5:05pm
FWP
ATXI
Avenue Therapeutics Inc
3 Oct 23
Free writing prospectus
5:47pm
S-1/A
ATXI
Avenue Therapeutics Inc
IPO registration (amended)
29 Sep 23
5:23pm
8-K
ATXI
Avenue Therapeutics Inc
28 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:25pm
8-K
ATXI
Avenue Therapeutics Inc
27 Sep 23
Other Events
4:03pm
UPLOAD
ATXI
Avenue Therapeutics Inc
21 Sep 23
Letter from SEC
12:00am
S-1
ATXI
Avenue Therapeutics Inc
IPO registration
18 Sep 23
5:18pm
SC 13D/A
ATXI
Avenue Therapeutics Inc
18 Sep 23
AVENUE THERAPEUTICS / Fortress Biotech ownership change
5:08pm
4
ATXI
Avenue Therapeutics Inc
12 Sep 23
AVENUE THERAPEUTICS / LINDSAY A MD ROSENWALD ownership change
9:03am
4
ATXI
Avenue Therapeutics Inc
12 Sep 23
Change in insider ownership
9:02am
8-K
ATXI
Avenue Therapeutics Inc
8 Sep 23
Entry into a Material Definitive Agreement
4:15pm
10-Q
2023 Q2
ATXI
Avenue Therapeutics Inc
Quarterly report
11 Aug 23
4:25pm
8-K
ATXI
Avenue Therapeutics Inc
10 Aug 23
Avenue Therapeutics Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
4:20pm